4.7 Article

Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout

Robert T. Keenan et al.

AMERICAN JOURNAL OF MEDICINE (2011)

Article Orthopedics

Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population

Paola Primatesta et al.

BMC MUSCULOSKELETAL DISORDERS (2011)

Article Allergy

The burden of adult asthma in the United States: Evidence from the Medical Expenditure Panel Survey

Patrick W. Sullivan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Medicine, General & Internal

Gout therapeutics: new drugs for an old disease

Christopher M. Burns et al.

LANCET (2011)

Article Health Care Sciences & Services

Catalogue of EQ-5D Scores for the United Kingdom

Patrick W. Sullivan et al.

MEDICAL DECISION MAKING (2011)

Article Rheumatology

New insights into the epidemiology of gout

Michael Doherty

RHEUMATOLOGY (2009)

Article Criminology & Penology

Overdispersion and poisson regression

Richard Berk et al.

JOURNAL OF QUANTITATIVE CRIMINOLOGY (2008)

Article Rheumatology

Quality of care for gout in the US needs improvement

Jasvinder A. Singh et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)

Review Geriatrics & Gerontology

Management of gout in older adults - Barriers to optimal control

Karl T. Hoskison et al.

DRUGS & AGING (2007)

Article Medicine, General & Internal

The economic burden of gout on an employed population

Richard A. Brook et al.

CURRENT MEDICAL RESEARCH AND OPINION (2006)

Article Rheumatology

Serum urate levels and gout flares - Analysis from managed care data

CA Sarawate et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2006)

Review Pharmacology & Pharmacy

Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors

HF Cheng et al.

CURRENT PHARMACEUTICAL DESIGN (2005)

Review Pharmacology & Pharmacy

A literature review of the epidemiology and treatment of acute gout

KY Kim et al.

CLINICAL THERAPEUTICS (2003)